GHK-Cu (Copper Peptide) vs PE-22-28

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

GHK-Cu (Copper Peptide)

GHK-Cu is a naturally occurring copper peptide found in human plasma, saliva, and urine. It plays important roles in wound healing, tissue repair, and has shown anti-aging properties in research.

Full details →

PE-22-28

PE-22-28 is a synthetic peptide fragment derived from research on the SAMP8 mouse model of accelerated aging. It has shown potential for enhancing memory and reducing cognitive decline.

Full details →

Side-by-Side Comparison

AspectGHK-Cu (Copper Peptide)PE-22-28
MechanismAttracts immune cells and fibroblasts to wound sites, stimulates collagen and glycosaminoglycan synthesis, promotes angiogenesis, and has antioxidant effects. Modulates gene expression related to tissue repair.Derived from the protein that is deficient in SAMP8 mice. May work by inhibiting protein phosphatase 2A methylesterase, thereby affecting memory-related signaling pathways.
Typical DosageTopical: Applied as serum or cream 1-2 times daily. Injectable: 1-2mg daily for research purposes. Microneedling protocols often use 0.5-1%.Research protocols vary. Intranasal dosing has been studied at various concentrations. Optimal human dosing not established.
AdministrationMost commonly used topically for skin applications. Can be injected subcutaneously for systemic effects. Often combined with microneedling for enhanced skin penetration.Intranasal administration preferred for CNS delivery. Research compound with limited human use data.
Side EffectsTopical use is generally well-tolerated. May cause temporary skin irritation or redness in sensitive individuals. Injectable use may cause injection site reactions.Very limited human data. Primarily studied in animal models for safety and efficacy.
Best For

What They Have in Common

Both GHK-Cu (Copper Peptide) and PE-22-28 are commonly used for:

Key Differences

Unique to GHK-Cu (Copper Peptide):

Unique to PE-22-28:

Ready to Learn More?